{"filing":{"accession_number":"0001104659-26-099221","cik":"0001761612","ticker":"BCYC","company_name":"BICYCLE THERAPEUTICS PLC","form":"8-K","filing_date":"2026-08-20","report_date":"2026-08-18","primary_document":"tm2623656d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926099221/tm2623656d1_8k.htm"},"events":[{"id":28842,"run_id":26396,"accession_number":"0001104659-26-099221","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Charles Swanton resigned as a Class II director of the Board effective immediately on August 18, 2026. The disclosure centers on the departure of a director from the Company's Board and its committees, with no appointment or compensation arrangement being the principal action. The resignation is material as it affects the composition of the Board and its governance structure.","company_name":"BICYCLE THERAPEUTICS PLC","ticker":"BCYC","filing_date":"2026-08-20","form":"8-K","submitted_at":null,"items":[{"id":30904,"accession_number":"0001104659-26-099221","item_number":"5.02","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Charles Swanton resigned as a Class II director of the Board effective immediately on August 18, 2026. The disclosure centers on the departure of a director from the Company's Board and its committees, with no appointment or compensation arrangement being the principal action. The resignation is material as it affects the composition of the Board and its governance structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-20T20:06:56.793071+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":30904,"accession_number":"0001104659-26-099221","item_number":"5.02","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Charles Swanton resigned as a Class II director of the Board effective immediately on August 18, 2026. The disclosure centers on the departure of a director from the Company's Board and its committees, with no appointment or compensation arrangement being the principal action. The resignation is material as it affects the composition of the Board and its governance structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-20T20:06:56.793071+00:00","company_name":"BICYCLE THERAPEUTICS PLC","ticker":"BCYC","filing_date":"2026-08-20"}]}